Every 10-Q that CANNABIS SUISSE CORP (CSUI) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow CSUI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CSUI filings page.
Cannabis Suisse Corp. reports a small profit while remaining under severe financial strain. For the nine months ended February 28, 2026, the company earned net income of $63,207, mainly from non-cash amortization of debt premiums rather than ongoing operations.
The business generated no revenue this quarter after its only sublease ended in February 2025. Operating expenses were $69,394 for the quarter and $228,909 for nine months. Total other income was $292,116, largely from amortizing prior convertible note premiums.
Liquidity remains extremely weak: cash was just $75 with a working capital deficit of $357,644 and an accumulated deficit of $2,993,839. Total assets were $455,714 against liabilities of $2,194,479, leaving a stockholders’ deficit of $1,738,765.
Management states there is substantial doubt about the company’s ability to continue as a going concern and expects to rely on related-party funding and potential capital market transactions. Internal controls over financial reporting are described as ineffective, with material weaknesses in governance, segregation of duties, and IT controls.
Cannabis Suisse Corp. reported a small profit but remains in fragile financial condition for the quarter ended November 30, 2025. The company generated no revenue in the quarter or year-to-date, compared with rental income of $7,500 and $15,000 in the prior-year periods, after its only sublease was terminated in February 2025.
Despite the lack of revenue, Cannabis Suisse posted net income of $22,392 for the quarter and $36,299 for the six months, driven largely by non-cash amortization of premiums on related-party convertible notes. The balance sheet shows total assets of $510,025 against liabilities of $2,275,698, resulting in a stockholders’ deficit of $1,765,673 and a working capital deficit of $316,580
Management discloses an accumulated deficit of $3,020,747 and states there is substantial doubt about the company’s ability to continue as a going concern. Operations are being funded primarily through advances and lease arrangements with the CEO and entities he controls, and the company also reports material weaknesses in internal controls and governance.
Cannabis Suisse Corp. reported a small net profit of $13,907 for the three months ended August 31, 2025, after a prior-year net loss of $535,086. The improvement came despite revenue falling to $0 from $7,500 as its only sub-lease was terminated, with results driven largely by non-cash amortization of debt premiums and related-party financing arrangements.
Total operating expenses rose to $84,535, mainly from higher general and administrative and rental costs now borne without sub-lease income. The company remains highly leveraged to related parties, with total liabilities of $2,358,409 against total assets of $570,344 and a stockholders’ deficit of $1,788,065.
The filing reiterates substantial doubt about the company’s ability to continue as a going concern, given limited revenues, an accumulated deficit of $3,043,139, working capital deficit of $273,201, and cash of only $305, leaving it reliant on loans and advances from its CEO and other related-party financing. Management also discloses material weaknesses in internal controls, including lack of an independent board, weak governance, and inadequate segregation of duties.